Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Operating Expenses | 7,101 | 4,911 | 4,651 | 3,839 | 4,273 |
| Operating Income | -7,101 | -4,911 | -4,651 | -3,839 | -4,273 |
| Other Income | 621 | 1 | 95 | 1 | 48 |
| Pre-tax Income | -6,480 | -4,910 | -4,556 | -3,838 | -4,225 |
| Net Income Continuous | -6,480 | -4,910 | -4,556 | -3,838 | -4,225 |
| Net Income | $-6,480 | $-4,910 | $-4,556 | $-3,838 | $-4,226 |
| EPS Basic Total Ops | -786.71 | -699.30 | -699.30 | -611.89 | -699.30 |
| EPS Basic Continuous Ops | -801.01 | -734.25 | -681.31 | -575.22 | -773.01 |
| EPS Diluted Total Ops | -786.71 | -699.30 | -699.30 | -611.89 | -699.30 |
| EPS Diluted Continuous Ops | -801.01 | -734.25 | -681.31 | -575.22 | -773.01 |
| EBITDA(a) | $-7,094 | $-4,905 | $-4,647 | $-3,836 | $-4,263 |